Neuroendocrine Tumors Clinical Trials in Iowa City, Iowa

4 studies are recruiting for neuroendocrine tumors in Iowa City, Iowa right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

    The primary objectives are to determine the recommended Phase 2 dose (RP2D) and optimal treatment regimen, characterize safety and tolerability, and evaluate preliminary efficacy of RYZ401 in subjects with NETs and other selected solid tumors expressing SSTRs.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Research Facility, Iowa City, Iowa
    Locations
    14 in total
    Run by
    RayzeBio, Inc.

    See if you can join NCT07165132 on ClinicalTrials.gov

  2. Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

    This study aims to determine the safety, pharmacokinetics (PK) and recommended Phase 3 dose (RP3D) of RYZ101 in Part 1, and the safety, efficacy, and PK of RYZ101 compared with investigator-selected standard of care (SoC) therapy in Part 2 in subjects with inoperable, advanced, well-differentiated,…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Research Facility, Iowa City, Iowa
    Locations
    54 in total
    Run by
    RayzeBio, Inc.

    See if you can join NCT05477576 on ClinicalTrials.gov

  3. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical…

    Stage
    Not phased
    Ages
    Any age
    Site
    Massive Bio SYNERGY-AI site, Iowa City, Iowa
    Locations
    68 in total
    Run by
    Massive Bio, Inc.

    See if you can join NCT03452774 on ClinicalTrials.gov

  4. 177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry

    The goal of this study is to learn if individualized dosimetry-based prescribing of Lutetium-177 DOTATATE (Lutathera, Novartis Pharmaceuticals) improves treatment outcomes for adults with unresectable neuroendocrine tumors. To investigate this, study participants will: * Undergo Somatostatin Recept…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Holden Comprehensive Cancer Center at the University of Iowa, Iowa City, Iowa
    Run by
    University of Iowa

    See if you can join NCT06395402 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.